The past decade has seen a remarkable explosion in our knowledge of the size and diversity
of the myosin superfamily. Since these actin-based motors are candidates to provide the …

The rapid development of genomic sequencing technologies has decreased the cost of
genetic analysis to the extent that it seems plausible that genomescale sequencing could have …

The Clinical Sequencing Evidence-Generating Research (CSER) consortium, now in its
second funding cycle, is investigating the effectiveness of integrating genomic (exome or …

Short-read genome sequencing (GS) holds the promise of becoming the primary diagnostic
approach for the assessment of autism spectrum disorder (ASD) and fetal structural …

Newborn screening (NBS) was established as a public health program in the 1960s and is
crucial for facilitating detection of certain medical conditions in which early intervention can …

Purpose: As genome-scale sequencing is increasingly applied in clinical scenarios, a wide
variety of genomic findings will be discovered as secondary or incidental findings, and there …

Harmonization of variant pathogenicity classification across laboratories is important for
advancing clinical genomics. The two CLIA-accredited Electronic Medical Record and Genomics …

Purpose We investigated the diagnostic and clinical performance of trio exome sequencing (ES)
in parent–fetus trios where the fetus had sonographic abnormalities but normal …

We report 21 families displaying neurodevelopmental differences and multiple congenital
anomalies while bearing a series of rare variants in mitogen-activated protein kinase kinase …

Objective To assess the performance of a standardized, age-based metric for scoring clinical
actionability to evaluate conditions for inclusion in newborn screening and compare it with …